Solvay: UBS Group Exceeds 3% Threshold in Financial Instruments
UBS Group AG has crossed the 3% threshold in the capital of Solvay, according to a transparency notification sent to the Belgian chemical group. The threshold crossing occurred on December 5, 2025.
According to the press release issued on December 15, 2025, UBS Group notified Solvay that it had exceeded the 3% threshold in total voting rights. The total participation of the Swiss banking group now stands at 3.37%, up from 3.05% previously. This increase is primarily due to a rise in equivalent financial instruments, which moved from 2.88% to 3.20%, while direct voting rights remained stable at 0.17%. According to the notification dated December 10, 2025, the threshold crossing was carried out on December 5, 2025. The denominator used for the calculation amounts to 105,876,416 shares.
Regulatory Compliance and Notification
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The company indicates that the obligation to declare arises because the indirect participations of UBS Group in the voting rights of Solvay, held directly by controlled companies, exceeded the regulatory threshold of 3% on December 5, 2025. The notifying party is UBS Group AG, whose head office is located at Bahnhofstrasse 45, 8001 Zurich. This notification is in accordance with Belgian financial transparency legislation, governed by the law of May 2, 2007. The complete chain of companies controlled through which the participation is effectively held is available in the Investor Relations section of Solvay's website.
About Solvay
Solvay is a Belgian chemical group that employs 9,000 people worldwide. Since its founding in 1863, the group has been developing chemical solutions for various sectors, including air purification, water preservation, health protection, and the enhancement of the sustainability of manufactured products. According to the press release, Solvay has set a goal to achieve carbon neutrality by 2050. The group reported a net revenue of 4.7 billion euros in 2024. Solvay is listed on the Euronext markets in Brussels and Paris under the ticker symbol SOLB.
Challenging market environment, excluding potential recovery measures from Sadara, updated guidance reflects Middle East impact
Risks mentioned
Middle East conflict impact of approximately €-25 million on underlying EBITDA in Q3 2026
Continued shutdown of the Peroxide plant at the Sadara complex in Jubail, Saudi Arabia accounted for €-15 million in Q3 2026
Challenging market environment affecting Group performance in Q3 2026
Opportunities identified
Joint venture contractual framework includes mechanisms designed to recover lost profitability from Sadara shutdown
Group exploring all available avenues to mitigate financial impact of shutdown
Transformation program and focus on cash generation and cost savings targets
Outlook / guidance
Expected EBITDA: 730 millions d'euros
Management commentary: In light of these developments, Solvay has reviewed its full-year 2026 guidance. Excluding potential revenue or recovery measures from Sadara for the remainder of 2026, the updated guidance is: Underlying EBITDA between €720 and €740 million
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.